Institutional and editorial misconduct in the MMR scareBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1680 (Published 15 March 2011) Cite this as: BMJ 2011;342:d1680
The BMJ should have declared competing interests in relation to this Editor’s Choice by Fiona Godlee (BMJ 2011;342:d378, doi:10.1136/bmj.d378). The BMJ Group receives advertising and sponsorship revenue from vaccine manufacturers, and specifically from Merck and GSK, which both manufacture MMR vaccines. For further information see the rapid response from Godlee (www.bmj.com/content/342/bmj.d1335.full/reply#bmj_el_251470). The same omission also affected two other related articles by Godlee (BMJ 2011;342:c7452 and BMJ 2011;342:d22).
Cite this as: BMJ 2011;342:d1680